Inventor · disambiguated record
Raffi Afeyan
Also filed as: AFEYAN RAFFI
11 granted patents·16 pending applications·74 citations·filing 2017–2025
90Inventor score
Top patents by PatentIndex Score
27 records- 0197US10201513B2Amino acid compositions and methods for the treatment of liver diseasesAXCELLA HEALTH INC·Filed 2018·Granted Feb 12, 2019·15 cites·11 claims
- 0296US10238617B2Amino acid compositions and methods for the treatment of liver diseasesAXCELLA HEALTH INC·Filed 2017·Granted Mar 26, 2019·16 cites·20 claims
- 0395US10471034B2Amino acid compositions and methods for the treatment of liver diseasesAXCELLA HEALTH INC·Filed 2018·Granted Nov 12, 2019·16 cites·20 claims
- 0494US10973793B2Compositions and methods for the treatment of fat infiltration in muscleAXCELLA HEALTH INC·Filed 2020·Granted Apr 13, 2021·4 cites·20 claims
- 0594US10682325B2Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wastingAXCELLA HEALTH INC·Filed 2018·Granted Jun 16, 2020·8 cites·42 claims
- 0693US10660870B2Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wastingAXCELLA HEALTH INC·Filed 2019·Granted May 26, 2020·7 cites·28 claims
- 0792US11129804B2Amino acid compositions and methods for the treatment of liver diseasesAXCELLA HEALTH INC·Filed 2017·Granted Sep 28, 2021·5 cites·35 claims
- 0884US11602511B2Amino acid compositions and methods for the treatment of liver diseasesAXCELLA HEALTH INC·Filed 2020·Granted Mar 14, 2023·1 cites·17 claims
- 0983US11571404B2Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wastingAXCELLA HEALTH INC·Filed 2020·Granted Feb 7, 2023·1 cites·25 claims
- 1082US2024041810A1Amino acid compositions and methods for the treatment of liver diseasesAXCELLA HEALTH INC·Filed 2023·Application pending·0 cites
- 1174US11058654B2Compositions and methods for the treatment of hemoglobinopathies and thalassemiasAXCELLA HEALTH INC·Filed 2019·Granted Jul 13, 2021·1 cites·14 claims
- 1271US2024238232A1Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditionsAXCELLA HEALTH INC·Filed 2023·Application pending·0 cites
- 1366US2023203158A1Methods for modulating intestine cells or tissue functionFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2022·Application pending·0 cites
- 1463US2021290574A1Compositions and methods for the treatment of hemoglobinopathies and thalassemiasAXCELLA HEALTH INC·Filed 2021·Application pending·0 cites
- 1562US2018207119A1Amino acid compositions and methods for the treatment of muscle diseases and disordersAXCELLA HEALTH INC·Filed 2017·Application pending·0 cites
- 1662US2018169047A1Amino acid compositions and methods for the treatment of muscle diseases and disordersAXCELLA HEALTH INC·Filed 2017·Application pending·0 cites
- 1762US2025353906A1Compositions and methods for targeted delivery of therapeutic agentsFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2023·Application pending·0 cites
- 1862US2018169046A1Amino acid compositions and methods for the treatment of muscle diseases and disordersAXCELLA HEALTH INC·Filed 2017·Application pending·0 cites
- 1961US2021275479A1Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditionsAXCELLA HEALTH INC·Filed 2019·Application pending·0 cites
- 2057US2019046486A1Compositions and methods for the treatment of neuronal injuryAXCELLA HEALTH INC·Filed 2018·Application pending·0 cites
- 2156US2025163151A1Methods for modulating intestine cells or tissue functionFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2025·Application pending·0 cites
- 2254US11617731B2Amino acid compositions and their use for the treatment of traumatic brain injuryAXCELLA HEALTH INC·Filed 2018·Granted Apr 4, 2023·0 cites·8 claims
- 2351US2021260010A1Compositions and methods for the reduction or treatment of inflammationAXCELLA HEALTH INC·Filed 2019·Application pending·0 cites
- 2446US2023105984A1Compositions and methods for the treatment of liver diseases and disordersDAOU NADINE·Filed 2020·Application pending·0 cites
- 2543US2021275480A1Compositions and methods for the reduction or treatment of fibrosisAXCELLA HEALTH INC·Filed 2019·Application pending·0 cites
- 2642US2023000808A1Compositions and methods excluding or with reduced glutamine for the treatment of hemoglobinopathies and thalassemiasWANI REVATI·Filed 2020·Application pending·0 cites
- 2741US2019388377A1Compositions and methods for the treatment of liver diseases and disordersAXCELLA HEALTH INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raffi Afeyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →